XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William Shapiro, MD
Barrow Neurological Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Ottawa Regional Cancer Centre
Ottawa, Ontario, Canada
- Barrow Neurological Institute
Phoenix, Arizona, United States
- Uc San Diego Cancer Center
La Jolla, California, United States
- Hoag Memorial Hospital Presbyterian
Newport Beach, California, United States
- Stanford University Medical Center
Palo Alto, California, United States
- Uc Davis Medical Center
Sacramento, California, United States
- University of Colorado Cancer Center
Aurora, Colorado, United States
- Moffitt Cancer Center and Research
Tampa, Florida, United States
- Winship Cancer Institute, Emory University
Atlanta, Georgia, United States
- Northwestern University, Feinberg School of Medicine
Chicago, Illinois, United States
- Evanston Northwestern Healthcare
Evanston, Illinois, United States
- Beth Israel Deaconess Med Center
Boston, Massachusetts, United States
- Field Neurosciences Institute
Saginaw, Michigan, United States
- Neurology Group of Bergen County
Ridgewood, New Jersey, United States
- Dent Neurologic Institute
Amherst, New York, United States
- Weill Medical College of Cornell University
New York, New York, United States
- Wake Forest University
Winston-Salem, North Carolina, United States
- Good Samaritan Hospital
Cincinnati, Ohio, United States
- University Hematology Oncology Care, Llc
Cincinnati, Ohio, United States
- the Ohio State University
Columbus, Ohio, United States
- Oregon Clinic
Portland, Oregon, United States
- Methodist Healthcare - University Hospital
Memphis, Tennessee, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- University of Wisconsin
Madison, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2006
- Primary completion
- —
- Completion
- 31 Jan 2008
- Last update posted
- 3 Jan 2008
- Registered enrollment
- 120
- Registry id
- NCT00226668
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.